Bone Marrow Biopsy | Clinical Trial Radar

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with University of Washington as a lead sponsor or collaborator. I can help you find nearby clinical trials and understand health conditions and treatments.

Let's discuss and explore clinical trials with University of Washington as a lead sponsor or collaborator.

I can help you find nearby clinical trials and understand health conditions and treatments.

Study Title Translate	Status	Conditions	Enr.	Update	Other IDs	Start	Completion	Lead Sponsor	Collaborators	Sites	Phase
Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma NCT07224100	Not yet recruiting	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1	33	04/11/2025	RG1125799NCI-2025-07631 (Registry Identifier) (CTRP (Clinical Trial Reporting Program))	01/05/2026	31/07/2028	University of Washington	Takeda	1	Phase 2
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma NCT07097363	Not yet recruiting	B-Cell Non-Hodgkin LymphomaBurkitt Lymphoma	18	20/10/2025	RG1125011NCI-2025-04889 (Registry Identifier) (CTRP (Clinical Trial Reporting Program))	01/01/2026	31/05/2030	University of Washington	AbbVie	1	Phase 2